CANNABIS BUZZ

Cannabis Stock

CANNABIS BUZZ Pure play marijuana stocks are scarce. Most companies in the marijuana industry trade over the counter (OTC), where solid information regarding operations and financials is difficult to retrieve. Exceptions extend to issues such as GW Pharmaceuticals plc (NASDAQ: GWPH), a British biopharmaceutical company that developed two cannabis-based drugs licensed for use outside the United States. Sativex is used to treat muscular contractions in multiple sclerosis patients, and Epidiolex targets epileptic seizures in children. Both drugs have entered Phase 3 clinical stage trials in the United States. GWPH has a $2 billion market cap and had returned 23% year to date (YTD) as of Aug. 15, 2016.

Political and legal obstacles remain the highest hurdles for the marijuana industry in 2016. Four states, Oregon, Washington, Alaska and Colorado, have legalized recreational marijuana, and 25 states plus the District of Columbia have approved cannabis for medicinal purposes. The plant is categorized at the federal level as a Schedule 1 drug, possessing the highest risk for psychological and physical dependence, and more curiously, having no acceptable medical use.

GB Sciences Exceeds Its Gross Revenue Projections for October, Doubles the Industry Average Yield Per Active Flower Light GB Sciences, Inc. (GBLX) announces that it has exceeded the October gross revenue projection of $500K from the sale of the premium flower by 2%. Gross sales projections for the month of November are also trending in […]

Friday Night Inc. Receives Approval from Clark County to Cultivate Cannabis on New Property VANCOUVER, B.C., CANADA (Nov 9th, 2017) – Friday Night Inc. (Friday Night) (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF) has received approval on its land use application from the Clark County Commissioners hearing, held on November 8th, to cultivate cannabis on […]